The pharma giant aims to be ready to go to market immediately once its vaccine has been tested and approved by the FDA. Its vaccine could be ready early next year.
“We have from the beginning decided we are going to do this not for profit so that the vaccine becomes affordable and available on a global scale as quickly as possible,” says Stoffels.
Two vaccine trials are already under way in the U.S. and China, including one led by Massachusetts-based Moderna, whilst a number of others are due to start imminently. “We could still fail. Moderna could fail... And then there are 10 billion people in the world who maybe need a vaccine. So there's going to be space enough for vaccines.”
Since January, scientists at the pharma giant were cutting the spike into different pieces to see which piece of the protein produced the best immune response, Stoffels says. Equally important was that the protein could be mass produced, he adds. “That's why it took like 10 weeks to do this to make sure we have the best immunogenicity as well as the most optimized production.”Moderna, which has been quick to kick off a trial with the U.S.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson, U.S. government plan one billion doses of coronavirus vaccineJohnson & Johnson said on Monday it made a $1 billion deal with the U.S. government to create enough manufacturing capacity for more than 1 billion doses of a vaccine it is testing to fight the new coronavirus that has killed more than 34,000 people around the world.
Read more »
Johnson & Johnson says human testing of its coronavirus vaccine to begin by SeptemberJohnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021.
Read more »
These are the companies working on a U.S. coronavirus treatment or vaccineFrom giants such Johnson & Johnson to smaller biotechs such as Inovio, more than a dozen companies are working to find a vaccine or treatment for the coronavirus pandemic.
Read more »
Johnson & Johnson wants to test its coronavirus vaccine by SeptemberPharmaceutical giant Johnson & Johnson plans to begin human clinical trials of its Covid-19 vaccine by September with a goal of the first batches being made available for emergency use authorization by early next year, according to a company announcement released Monday.
Read more »
The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & JohnsonThe largest reported contract for a coronavirus vaccine has gone to a pharma giant that’s yet to start clinical trials
Read more »
UK PM Johnson's adviser Cummings isolating with coronavirus symptomsThe coronavirus outbreak at the heart of the UK government spread on Monday with Prime Minister Boris Johnson's senior adviser, Dominic Cummings, self-isolating with symptoms just days after the British leader himself tested positive.
Read more »